ABO-incompatible liver transplantation for critically ill adult patients

Transplant International

Volumn 20, Issue 8, 2007, Pages 675-681

  Toso, Christian ^b   Al Qahtani, Mohammed ^b   Alsaif, Faisal A ^b   Bigam, David L ^b   Meeberg, Glenda A ^b   James Shapiro, A M ^b   Bain, Vincent G ^b   Kneteman, Norman M ^a,b  

^a 2D441 Walter Mackenzie Center ^*  (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ABO incompatible; Liver failure; Liver transplantation; Urgent

Indexed keywords

AGGLUTININ; ANTIMETABOLITE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CEFOTAXIME; COTRIMOXAZOLE; DACLIZUMAB; GANCICLOVIR; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; RAPAMYCIN; STEROID; TACROLIMUS; VALGANCICLOVIR;

ADULT; ARTERY THROMBOSIS; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG DOSE TITRATION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; INTUBATION; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ALBERTA; CRITICAL ILLNESS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34347407580     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00492.x     Document Type: Article

References (20)

1. Guggenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990 336: 519.
2. Reding R, Veyckemans F, de Ville de Goyet J, et al. ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet 1992 174: 59.
3. Farges O, Nocci Kalil A, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995 59: 1124.
4. Wu A, Buhler L, Cooper D. ABO-incompatible organ and bone marrow transplantation: current status. Transplant Int 2003 16: 291.
5. Hanto DW, Fecteau A, Alonso M, Valente J, Whiting J. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy and quadruple immunosuppression: evidence for accommodation. Liver Transplant 2003 9: 22.
6. Sugawara Y, Makuuchi M. Adult liver transplantation using live ABO-incompatible grafts in Western countries. Liver Transplant 2006 12: 1324.
7. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004 77: 403.
8. Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002 73: 1959.
9. Nakamura Y, Matsuno N, Iwamoto H, et al. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report. Transplant Proc 2004 36: 2269.
10. Bjoro K, Ericzon B, Kirkegaard P, et al. Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 2003 75: 347.
11. Skogsberg U, Breimer M, Friman S, et al. Adult ABO-incompatible liver transplantation, using A and B donors. Xenotransplantation 2006 13: 154.
12. Hatano E, Terajima H, Yabe S, et al. Hepatic artery thrombosis in living related liver transplantation. Transplantation 1997 10: 1443.
13. Rydberg L, Bengtsson A, Samuelsson O, Nilsson K, Breimer M. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transplant Int 2005 17: 666.
14. Troisi R, Noens L, Montalti R, et al. ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppresion without splenectomy. Liver Transplant 2006 12: 1412.
15. Usuda M, Fujimori K, Koyamada N, et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation 2005 79: 12.
16. Yoshizawa A, Sakamoto S, Ogawa K, et al. New protocol of imunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion and preservation of spleen. Transplant Proc 2005 37: 1718.
17. Kawagishi N, Satoh K, Enomoto Y, et al. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange. Transplant Proc 2005 37: 1205.
18. Becker Y, Samaniego-Picota M, Sollinger H. The emerging role of rituximab in organ transplantation. Transplant Int 2006 19: 621.
19. Wiesner R, Rabkin J, Klintmalm G, et al. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transplant 2001 7: 442.
20. European FK506 Multicentre Liver Study Group. Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994 344: 423.